Niesvizky R - Search Results

1

Novel and engineered anti-B-cell monoclonal antibodies for non-Hodgkin's lymphoma.

Martin P, Furman RR, Ruan J, Elstrom R, Barrientos J, Niesvizky R, Coleman M, Leonard JP. Martin P, et al. Among authors: niesvizky r. Semin Hematol. 2008 Apr;45(2):126-32. doi: 10.1053/j.seminhematol.2008.02.007. Semin Hematol. 2008. PMID: 18381108 Review.

2

BLT-D (clarithromycin [Biaxin], low-dose thalidomide, and dexamethasone) for the treatment of myeloma and Waldenström's macroglobulinemia.

Coleman M, Leonard J, Lyons L, Pekle K, Nahum K, Pearse R, Niesvizky R, Michaeli J. Coleman M, et al. Among authors: niesvizky r. Leuk Lymphoma. 2002 Sep;43(9):1777-82. doi: 10.1080/1042819021000006303. Leuk Lymphoma. 2002. PMID: 12685831

3

Treatment of Waldenstrom's macroglobulinemia with clarithromycin, low-dose thalidomide, and dexamethasone.

Coleman M, Leonard J, Lyons L, Szelenyi H, Niesvizky R. Coleman M, et al. Among authors: niesvizky r. Semin Oncol. 2003 Apr;30(2):270-4. doi: 10.1053/sonc.2003.50044. Semin Oncol. 2003. PMID: 12720151 Clinical Trial.

4

Combination antibody therapy with epratuzumab and rituximab in relapsed or refractory non-Hodgkin's lymphoma.

Leonard JP, Coleman M, Ketas J, Ashe M, Fiore JM, Furman RR, Niesvizky R, Shore T, Chadburn A, Horne H, Kovacs J, Ding CL, Wegener WA, Horak ID, Goldenberg DM. Leonard JP, et al. Among authors: niesvizky r. J Clin Oncol. 2005 Aug 1;23(22):5044-51. doi: 10.1200/JCO.2005.13.821. Epub 2005 Jun 13. J Clin Oncol. 2005. PMID: 15955901 Clinical Trial.

5

Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma.

Leonard JP, Coleman M, Kostakoglu L, Chadburn A, Cesarman E, Furman RR, Schuster MW, Niesvizky R, Muss D, Fiore J, Kroll S, Tidmarsh G, Vallabhajosula S, Goldsmith SJ. Leonard JP, et al. Among authors: niesvizky r. J Clin Oncol. 2005 Aug 20;23(24):5696-704. doi: 10.1200/JCO.2005.14.803. J Clin Oncol. 2005. PMID: 16110029 Clinical Trial.

6

Subsequent therapy can be administered after tositumomab and iodine I-131 tositumomab for non-Hodgkin lymphoma.

Dosik AD, Coleman M, Kostakoglu L, Furman RR, Fiore JM, Muss D, Niesvizky R, Shore T, Schuster MW, Stewart P, Vallabhajosula S, Goldsmith SJ, Leonard JP. Dosik AD, et al. Among authors: niesvizky r. Cancer. 2006 Feb 1;106(3):616-22. doi: 10.1002/cncr.21606. Cancer. 2006. PMID: 16362977 Free article.

7

Lenalidomide-induced myelosuppression is associated with renal dysfunction: adverse events evaluation of treatment-naïve patients undergoing front-line lenalidomide and dexamethasone therapy.

Niesvizky R, Naib T, Christos PJ, Jayabalan D, Furst JR, Jalbrzikowski J, Zafar F, Mark T, Lent R, Pearse RN, Ely S, Leonard JP, Mazumdar M, Chen-Kiang S, Coleman M. Niesvizky R, et al. Br J Haematol. 2007 Sep;138(5):640-3. doi: 10.1111/j.1365-2141.2007.06698.x. Br J Haematol. 2007. PMID: 17686058 Free article. Clinical Trial.

8

BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma.

Niesvizky R, Jayabalan DS, Christos PJ, Furst JR, Naib T, Ely S, Jalbrzikowski J, Pearse RN, Zafar F, Pekle K, Larow A, Lent R, Mark T, Cho HJ, Shore T, Tepler J, Harpel J, Schuster MW, Mathew S, Leonard JP, Mazumdar M, Chen-Kiang S, Coleman M. Niesvizky R, et al. Blood. 2008 Feb 1;111(3):1101-9. doi: 10.1182/blood-2007-05-090258. Epub 2007 Nov 7. Blood. 2008. PMID: 17989313 Free article. Clinical Trial.

9

Prophylactic low-dose aspirin is effective antithrombotic therapy for combination treatments of thalidomide or lenalidomide in myeloma.

Niesvizky R, Martínez-Baños D, Jalbrzikowski J, Christos P, Furst J, De Sancho M, Mark T, Pearse R, Mazumdar M, Zafar F, Pekle K, Leonard J, Jayabalan D, Coleman M. Niesvizky R, et al. Leuk Lymphoma. 2007 Dec;48(12):2330-7. doi: 10.1080/10428190701647887. Leuk Lymphoma. 2007. PMID: 18067007

10

Low-dose metronomic, multidrug therapy with the PEP-C oral combination chemotherapy regimen for mantle cell lymphoma.

Coleman M, Martin P, Ruan J, Furman R, Niesvizky R, Elstrom R, George P, Leonard J, Kaufmann T. Coleman M, et al. Among authors: niesvizky r. Leuk Lymphoma. 2008 Mar;49(3):447-50. doi: 10.1080/10428190701837330. Leuk Lymphoma. 2008. PMID: 18297520

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178 results

Search Page

Filters